Table of Contents

1 Market Overview
1.1 Cancer Treatment Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Chemotherapy
1.2.2 Targeted Therapy
1.2.3 Immunotherapy
1.2.4 Hormonal Therapy (Biologic Therapy)
1.2.5 Others
1.3 Market Analysis by Applications
1.3.1 Blood Cancer
1.3.2 Breast Cancer
1.3.3 Gastrointestinal Cancer
1.3.4 Prostate Cancer
1.3.5 Respiratory/Lung Cancer
1.3.6 Other Cancers
1.4 Market Analysis by Regions
1.4.1 North America (USA, Canada and Mexico)
1.4.1.1 USA Market States and Outlook (2012-2022)
1.4.1.2 Canada Market States and Outlook (2012-2022)
1.4.1.3 Mexico Market States and Outlook (2012-2022)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2012-2022)
1.4.2.2 France Market States and Outlook (2012-2022)
1.4.2.3 UK Market States and Outlook (2012-2022)
1.4.2.4 Russia Market States and Outlook (2012-2022)
1.4.2.5 Italy Market States and Outlook (2012-2022)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2012-2022)
1.4.3.2 Japan Market States and Outlook (2012-2022)
1.4.3.3 Korea Market States and Outlook (2012-2022)
1.4.3.4 India Market States and Outlook (2012-2022)
1.4.3.5 Southeast Asia Market States and Outlook (2012-2022)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2012-2022)
1.4.4.2 Egypt Market States and Outlook (2012-2022)
1.4.4.3 Saudi Arabia Market States and Outlook (2012-2022)
1.4.4.4 South Africa Market States and Outlook (2012-2022)
1.4.4.5 Nigeria Market States and Outlook (2012-2022)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Roche
2.1.1 Business Overview
2.1.2 Cancer Treatment Drugs Type and Applications
2.1.2.1 Type 1
2.1.2.2 Type 2
2.1.3 Roche Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Novartis
2.2.1 Business Overview
2.2.2 Cancer Treatment Drugs Type and Applications
2.2.2.1 Type 1
2.2.2.2 Type 2
2.2.3 Novartis Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Celgene
2.3.1 Business Overview
2.3.2 Cancer Treatment Drugs Type and Applications
2.3.2.1 Type 1
2.3.2.2 Type 2
2.3.3 Celgene Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Bristol-Myers Squibb
2.4.1 Business Overview
2.4.2 Cancer Treatment Drugs Type and Applications
2.4.2.1 Type 1
2.4.2.2 Type 2
2.4.3 Bristol-Myers Squibb Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Amgen
2.5.1 Business Overview
2.5.2 Cancer Treatment Drugs Type and Applications
2.5.2.1 Type 1
2.5.2.2 Type 2
2.5.3 Amgen Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Johnson & Johnson
2.6.1 Business Overview
2.6.2 Cancer Treatment Drugs Type and Applications
2.6.2.1 Type 1
2.6.2.2 Type 2
2.6.3 Johnson & Johnson Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Pfizer
2.7.1 Business Overview
2.7.2 Cancer Treatment Drugs Type and Applications
2.7.2.1 Type 1
2.7.2.2 Type 2
2.7.3 Pfizer Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Takeda
2.8.1 Business Overview
2.8.2 Cancer Treatment Drugs Type and Applications
2.8.2.1 Type 1
2.8.2.2 Type 2
2.8.3 Takeda Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Eli Lilly
2.9.1 Business Overview
2.9.2 Cancer Treatment Drugs Type and Applications
2.9.2.1 Type 1
2.9.2.2 Type 2
2.9.3 Eli Lilly Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 AstraZeneca
2.10.1 Business Overview
2.10.2 Cancer Treatment Drugs Type and Applications
2.10.2.1 Type 1
2.10.2.2 Type 2
2.10.3 AstraZeneca Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Astellas
2.11.1 Business Overview
2.11.2 Cancer Treatment Drugs Type and Applications
2.11.2.1 Type 1
2.11.2.2 Type 2
2.11.3 Astellas Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Merck & Co.
2.12.1 Business Overview
2.12.2 Cancer Treatment Drugs Type and Applications
2.12.2.1 Type 1
2.12.2.2 Type 2
2.12.3 Merck & Co. Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 Sanofi
2.13.1 Business Overview
2.13.2 Cancer Treatment Drugs Type and Applications
2.13.2.1 Type 1
2.13.2.2 Type 2
2.13.3 Sanofi Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.14 Bayer
2.14.1 Business Overview
2.14.2 Cancer Treatment Drugs Type and Applications
2.14.2.1 Type 1
2.14.2.2 Type 2
2.14.3 Bayer Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.15 Biogen Idec
2.15.1 Business Overview
2.15.2 Cancer Treatment Drugs Type and Applications
2.15.2.1 Type 1
2.15.2.2 Type 2
2.15.3 Biogen Idec Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.16 Eisai
2.16.1 Business Overview
2.16.2 Cancer Treatment Drugs Type and Applications
2.16.2.1 Type 1
2.16.2.2 Type 2
2.16.3 Eisai Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.17 Teva
2.17.1 Business Overview
2.17.2 Cancer Treatment Drugs Type and Applications
2.17.2.1 Type 1
2.17.2.2 Type 2
2.17.3 Teva Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.18 Otsuka
2.18.1 Business Overview
2.18.2 Cancer Treatment Drugs Type and Applications
2.18.2.1 Type 1
2.18.2.2 Type 2
2.18.3 Otsuka Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.19 Merck KGaA
2.19.1 Business Overview
2.19.2 Cancer Treatment Drugs Type and Applications
2.19.2.1 Type 1
2.19.2.2 Type 2
2.19.3 Merck KGaA Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.20 Ipsen
2.20.1 Business Overview
2.20.2 Cancer Treatment Drugs Type and Applications
2.20.2.1 Type 1
2.20.2.2 Type 2
2.20.3 Ipsen Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.21 AbbVie
2.21.1 Business Overview
2.2.2 Cancer Treatment Drugs Type and Applications
2.21.2.1 Type 1
2.21.2.2 Type 2
2.21.3 AbbVie Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.22 Gilead Sciences
2.22.1 Business Overview
2.22.2 Cancer Treatment Drugs Type and Applications
2.22.2.1 Type 1
2.22.2.2 Type 2
2.22.3 Gilead Sciences Cancer Treatment Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Cancer Treatment Drugs Market Competition, by Manufacturer
3.1 Global Cancer Treatment Drugs Sales and Market Share by Manufacturer
3.2 Global Cancer Treatment Drugs Revenue and Market Share by Manufacturer
3.3 Market Concentration Rate
3.3.1 Top 3 Cancer Treatment Drugs Manufacturer Market Share
3.3.2 Top 6 Cancer Treatment Drugs Manufacturer Market Share
3.4 Market Competition Trend
4 Global Cancer Treatment Drugs Market Analysis by Regions
4.1 Global Cancer Treatment Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Cancer Treatment Drugs Sales by Regions (2012-2017)
4.1.2 Global Cancer Treatment Drugs Revenue by Regions (2012-2017)
4.2 North America Cancer Treatment Drugs Sales and Growth (2012-2017)
4.3 Europe Cancer Treatment Drugs Sales and Growth (2012-2017)
4.4 Asia-Pacific Cancer Treatment Drugs Sales and Growth (2012-2017)
4.5 South America Cancer Treatment Drugs Sales and Growth (2012-2017)
4.6 Middle East and Africa Cancer Treatment Drugs Sales and Growth (2012-2017)
5 North America Cancer Treatment Drugs by Countries
5.1 North America Cancer Treatment Drugs Sales, Revenue and Market Share by Countries
5.1.1 North America Cancer Treatment Drugs Sales by Countries (2012-2017)
5.1.2 North America Cancer Treatment Drugs Revenue by Countries (2012-2017)
5.2 USA Cancer Treatment Drugs Sales and Growth (2012-2017)
5.3 Canada Cancer Treatment Drugs Sales and Growth (2012-2017)
5.4 Mexico Cancer Treatment Drugs Sales and Growth (2012-2017)
6 Europe Cancer Treatment Drugs by Countries
6.1 Europe Cancer Treatment Drugs Sales, Revenue and Market Share by Countries
6.1.1 Europe Cancer Treatment Drugs Sales by Countries (2012-2017)
6.1.2 Europe Cancer Treatment Drugs Revenue by Countries (2012-2017)
6.2 Germany Cancer Treatment Drugs Sales and Growth (2012-2017)
6.3 UK Cancer Treatment Drugs Sales and Growth (2012-2017)
6.4 France Cancer Treatment Drugs Sales and Growth (2012-2017)
6.5 Russia Cancer Treatment Drugs Sales and Growth (2012-2017)
6.6 Italy Cancer Treatment Drugs Sales and Growth (2012-2017)
7 Asia-Pacific Cancer Treatment Drugs by Countries
7.1 Asia-Pacific Cancer Treatment Drugs Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Cancer Treatment Drugs Sales by Countries (2012-2017)
7.1.2 Asia-Pacific Cancer Treatment Drugs Revenue by Countries (2012-2017)
7.2 China Cancer Treatment Drugs Sales and Growth (2012-2017)
7.3 Japan Cancer Treatment Drugs Sales and Growth (2012-2017)
7.4 Korea Cancer Treatment Drugs Sales and Growth (2012-2017)
7.5 India Cancer Treatment Drugs Sales and Growth (2012-2017)
7.6 Southeast Asia Cancer Treatment Drugs Sales and Growth (2012-2017)
8 South America Cancer Treatment Drugs by Countries
8.1 South America Cancer Treatment Drugs Sales, Revenue and Market Share by Countries
8.1.1 South America Cancer Treatment Drugs Sales by Countries (2012-2017)
8.1.2 South America Cancer Treatment Drugs Revenue by Countries (2012-2017)
8.2 Brazil Cancer Treatment Drugs Sales and Growth (2012-2017)
8.3 Argentina Cancer Treatment Drugs Sales and Growth (2012-2017)
8.4 Columbia Cancer Treatment Drugs Sales and Growth (2012-2017)
9 Middle East and Africa Cancer Treatment Drugs by Countries
9.1 Middle East and Africa Cancer Treatment Drugs Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Cancer Treatment Drugs Sales by Countries (2012-2017)
9.1.2 Middle East and Africa Cancer Treatment Drugs Revenue by Countries (2012-2017)
9.2 Saudi Arabia Cancer Treatment Drugs Sales and Growth (2012-2017)
9.3 UAE Cancer Treatment Drugs Sales and Growth (2012-2017)
9.4 Egypt Cancer Treatment Drugs Sales and Growth (2012-2017)
9.5 Nigeria Cancer Treatment Drugs Sales and Growth (2012-2017)
9.6 South Africa Cancer Treatment Drugs Sales and Growth (2012-2017)
10 Global Cancer Treatment Drugs Market Segment by Type
10.1 Global Cancer Treatment Drugs Sales, Revenue and Market Share by Type (2012-2017)
10.1.1 Global Cancer Treatment Drugs Sales and Market Share by Type (2012-2017)
10.1.2 Global Cancer Treatment Drugs Revenue and Market Share by Type (2012-2017)
10.2 Chemotherapy Sales Growth and Price
10.2.1 Global Chemotherapy Sales Growth (2012-2017)
10.2.2 Global Chemotherapy Price (2012-2017)
10.3 Targeted Therapy Sales Growth and Price
10.3.1 Global Targeted Therapy Sales Growth (2012-2017)
10.3.2 Global Targeted Therapy Price (2012-2017)
10.4 Immunotherapy Sales Growth and Price
10.4.1 Global Immunotherapy Sales Growth (2012-2017)
10.4.2 Global Immunotherapy Price (2012-2017)
10.5 Hormonal Therapy (Biologic Therapy) Sales Growth and Price
10.5.1 Global Hormonal Therapy (Biologic Therapy) Sales Growth (2012-2017)
10.5.2 Global Hormonal Therapy (Biologic Therapy) Price (2012-2017)
10.6 Others Sales Growth and Price
10.6.1 Global Others Sales Growth (2012-2017)
10.6.2 Global Others Price (2012-2017)
11 Global Cancer Treatment Drugs Market Segment by Application
11.1 Global Cancer Treatment Drugs Sales Market Share by Application (2012-2017)
11.2 Blood Cancer Sales Growth (2012-2017)
11.3 Breast Cancer Sales Growth (2012-2017)
11.4 Gastrointestinal Cancer Sales Growth (2012-2017)
11.5 Prostate Cancer Sales Growth (2012-2017)
11.6 Respiratory/Lung Cancer Sales Growth (2012-2017)
11.7 Other Cancers Sales Growth (2012-2017)
12 Cancer Treatment Drugs Market Forecast (2017-2022)
12.1 Global Cancer Treatment Drugs Sales, Revenue and Growth Rate (2017-2022)
12.2 Cancer Treatment Drugs Market Forecast by Regions (2017-2022)
12.2.1 North America Cancer Treatment Drugs Market Forecast (2017-2022)
12.2.2 Europe Cancer Treatment Drugs Market Forecast (2017-2022)
12.2.3 Asia-Pacific Cancer Treatment Drugs Market Forecast (2017-2022)
12.2.4 South America Cancer Treatment Drugs Market Forecast (2017-2022)
12.2.5 Middle East and Africa Cancer Treatment Drugs Market Forecast (2017-2022)
12.3 Cancer Treatment Drugs Market Forecast by Type (2017-2022)
12.4 Cancer Treatment Drugs Market Forecast by Application (2017-2022)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Analyst Introduction
15.3 Data Source